1. In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer
   Anna Torres et al, 2016, BMC Cancer CrossRef
2. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in�vitro
   Marc Hirschfeld et al, 2020, Molecular Medicine Reports CrossRef
3. Changes in the expression of cancer- and metastasis-related genes and proteins after metformin treatment under different metabolic conditions in endometrial cancer cells
   Carsten Lange et al, 2023, Heliyon CrossRef
4. Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro
   Julia Eismann et al, 2017, Oncology Reports CrossRef
5. Retracted: miR-142 Suppresses Endometrial Cancer Proliferation In Vitro and In Vivo by Targeting Cyclin D1
   Yi Su et al, 2019, DNA and Cell Biology CrossRef
6. Insulin Resistance and Endometrial Cancer: Emerging Role for microRNA
   Iwona Sidorkiewicz et al, 2020, Cancers CrossRef
7. The future therapy of endometrial cancer: microRNA’s functionality, capability, and putative clinical application
   Matthias B. Stope et al, 2016, Archives of Gynecology and Obstetrics CrossRef
8. The miR-200 family in ovarian cancer
   Maria Koutsaki et al, 2017, Oncotarget CrossRef
9. A guide for endometrial cancer cell lines functional assays using the measurements of electronic impedance
   Joanna Kozak et al, 2018, Cytotechnology CrossRef